Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
30 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bridge-biotherapeutics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302339220.html
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bridge-biotherapeutics-and-hitgen-initiate-research-collaboration-to-advance-novel-cancer-therapeutics-program-302228404.html
22 Aug 2024
// BIOSPACE
https://www.biospace.com/business/bridgebio-launches-gondolabio-with-300m-transfers-programs-to-joint-venture
29 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bridge-biotherapeutics-announces-completion-of-enrollment-in-the-phase-2a-clinical-study-of-bbt-877-for-the-treatment-of-idiopathic-pulmonary-fibrosis-302208799.html
28 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bridge-biotherapeutics-launches-a-research-collaboration-with-emory-university-school-of-medicine-to-explore-combination-therapy-of-bbt-877-for-krasp53-mutant-nsclc-patients-resistant-to-anti-pd-1-blockade-302098969.html
26 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bridge-biotherapeutics-announces-a-research-collaboration-with-the-university-of-colorado-school-of-medicine-to-explore-potential-of-bbt-877-for-immuno-oncology-302098937.html
ABOUT THIS PAGE